Ascend recalls dabigatran etexilate capsules due to nitrosamine impurity News item 08 April 2023 Pages: 1 - 1
JAK inhibitor safety information updated with risk minimisation measures News item 08 April 2023 Pages: 2 - 2
JAK inhibitors increase risk of MI, thrombosis, cancer and serious infections News item 08 April 2023 Pages: 3 - 3
Design criteria impact reference sets for signal detection algorithms for drug interactions Clinical study 08 April 2023 Pages: 8 - 8
Drug hypersensitivity reactions increase risk of anxiety and depression Clinical study 08 April 2023 Pages: 9 - 9
Experiences after first COVID-19 vaccination impact severity of AEs after second dose Clinical study 08 April 2023 Pages: 10 - 10
Fluoroquinolone: no impact of regulatory interventions to reduce use in the EU/UK Clinical study 08 April 2023 Pages: 11 - 11